Table 1.
Clinical and biochemical characteristics of the whole study population according to SARS-CoV-2 infection status.
| SARS-CoV-2 Infected Patients |
Uninfected Individuals | p-Value | |
|---|---|---|---|
| N | 40 | 21 | - |
| Age yr, median (IQR) a | 56 (50.25–64) | 37 (35–44.5) | <0.0001 |
| Female no. (%) b | 14 (35) | 15 (71.4) | 0.0068 |
| Albumin (g/L), median (IQR) a | 34.95 (31.10–37.78) | - | - |
| Bilirubin (mg/dL), median (IQR) a | 0.54 (0.42–0.64) | 0.47 (0.37–0.74) | 0.5944 |
| Creatinine mg/dL, median (IQR) a | 0.75 (0.66–0.89) | 0.78 (0.68–0.90) | 0.7790 |
| D-Dimer (µg/L), median (IQR) a | 453 (217–809) | - | - |
| Ferritin (ng/mL), median (IQR) a | 671 (315.1–1035) | - | - |
| Fibrinogen (mg/L), median (IQR) a | 654 (540–726) | - | - |
| Glucose (mg/dL), median (IQR) a | 102.20 (90.33–115) | - | - |
| ALT (U/L), median (IQR) a | 32 (19.75–58.50) | 15 (12–19.50) | <0.0001 |
| Potassium (mmol/L), median (IQR) a | 4.00 (3.71–4.36) | - | - |
| Sodium (mmol/L), median (IQR) a | 139.10 (136.80–141) | - | - |
| Urea (mg/dL), median (IQR) a | 32 (25–49) | - | - |
| Hematocrit %, median (IQR) a | 39.60 (34.60–44.90) | 41.25 (38.40–43.63) | 0.4708 |
| Hemoglobin (g/dL), median (IQR) a | 13.40 (11.93–15.48) | 14.20 (13.05–14.53) | 0.4353 |
| Mean Corpuscular Hemoglobin Concentration (g/dL), median (IQR) a | 30.20 (29.25–31.35) | 30.35 (29.65–31.93) | 0.4204 |
| Leucocyte count (×109/L), median (IQR) a | 5.50 (4.12–7.45) | 6.50 (5.70–8.92) | 0.0752 |
| Lymphocyte count (×109/L), median (IQR) a | 1.25(0.87–1.60) | 2.00 (1.77–2.67) | <0.0001 |
| Monocyte count (×109/L), median (IQR) a | 0.45 (0.30–0.70) | 0.50 (0.37–0.80) | 0.3963 |
| Platelet Distribution Width %, median (IQR) a | 17.20 (16.63–17.60) | 16.10 (15.78–16.55) | <0.0001 |
| Platelet (×109/L), median (IQR) a | 214 (169.30–301.50) | 253.50 (195.30–347.80) | 0.1798 |
| Interleukin 6 (pg/mL), median (IQR) a | 20.06 (9.53–52.69) | - | - |
a Mann–Whitney t test, b Chi-square test. interquartile range (IQR), alanine aminotransferase (ALT).